These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 25749031

  • 1. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
    Taliaferro-Smith L, Oberlick E, Liu T, McGlothen T, Alcaide T, Tobin R, Donnelly S, Commander R, Kline E, Nagaraju GP, Havel L, Marcus A, Nahta R, O'Regan R.
    Oncotarget; 2015 Mar 10; 6(7):4757-72. PubMed ID: 25749031
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK, Kim HS, Jin T, Hwang EH, Jung M, Moon WK.
    BMC Cancer; 2016 Aug 02; 16():570. PubMed ID: 27484639
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM, Lee WH, Wu AT, Lin YK, Wang LS, Wu CH, Yeh CT.
    J Nutr Biochem; 2015 Jun 02; 26(6):675-85. PubMed ID: 25792283
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling.
    Zhu Z, Wang H, Qian X, Xue M, Sun A, Yin Y, Tang J, Zhang J.
    Clin Breast Cancer; 2024 Jun 02; 24(4):e244-e257.e1. PubMed ID: 38378361
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells.
    Xu H, Qian M, Zhao B, Wu C, Maskey N, Song H, Li D, Song J, Hua K, Fang L.
    Oncol Rep; 2017 Mar 02; 37(3):1619-1626. PubMed ID: 28184936
    [Abstract] [Full Text] [Related]

  • 10. Ziyuglycoside II suppresses the aggressive phenotype of triple negative breast cancer cells through regulating Src/EGFR-dependent ITGB4/FAK signaling.
    Wang K, Zou P, Zhu X, Zhang T.
    Toxicol In Vitro; 2019 Dec 02; 61():104653. PubMed ID: 31525383
    [Abstract] [Full Text] [Related]

  • 11. NOTCH4 is a potential therapeutic target for triple-negative breast cancer.
    Nagamatsu I, Onishi H, Matsushita S, Kubo M, Kai M, Imaizumi A, Nakano K, Hattori M, Oda Y, Tanaka M, Katano M.
    Anticancer Res; 2014 Jan 02; 34(1):69-80. PubMed ID: 24403446
    [Abstract] [Full Text] [Related]

  • 12. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J, Li WZ, Huang ML, Wei HL, Wang T, Fan J, Li NL, Ling R.
    Biochem Biophys Res Commun; 2017 Jan 29; 483(1):10-16. PubMed ID: 28069384
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells.
    Rigiracciolo DC, Nohata N, Lappano R, Cirillo F, Talia M, Scordamaglia D, Gutkind JS, Maggiolini M.
    Cells; 2020 Apr 18; 9(4):. PubMed ID: 32325700
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas.
    Potratz JC, Saunders DN, Wai DH, Ng TL, McKinney SE, Carboni JM, Gottardis MM, Triche TJ, Jürgens H, Pollak MN, Aparicio SA, Sorensen PH.
    Cancer Res; 2010 Nov 01; 70(21):8770-81. PubMed ID: 20959493
    [Abstract] [Full Text] [Related]

  • 18. Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR.
    Wang YL, Overstreet AM, Chen MS, Wang J, Zhao HJ, Ho PC, Smith M, Wang SC.
    Oncotarget; 2015 May 10; 6(13):11150-61. PubMed ID: 25883211
    [Abstract] [Full Text] [Related]

  • 19. The effects of focal adhesion kinase on the motility, proliferation and apoptosis of Caco2 and SMMC-7721 cells.
    Gao N, He H, Xiao L, Gao X, Shi H, Wu Q, Xu N, Lei Y, Song X, Hou Y.
    Med Oncol; 2015 Apr 10; 32(4):125. PubMed ID: 25790781
    [Abstract] [Full Text] [Related]

  • 20. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV, Zhao N, Den Hollander P, Toneff MJ, Joseph R, Pietila M, Taube JH, Sarkar TR, Ramirez-Pena E, Werden SJ, Shariati M, Gao R, Sobieski M, Stephan CC, Sphyris N, Miura N, Davies P, Chang JT, Soundararajan R, Rosen JM, Mani SA.
    Breast Cancer Res; 2019 Mar 07; 21(1):37. PubMed ID: 30845991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.